Rx/reimbursement adult incontinence in Switzerland recorded 1% value growth to CHF40 million in 2025, driven by an ageing Swiss population requiring long-term care and consistent incontinence management. Units distributed through the reimbursement channel grew from 47.6 million in 2024 to 48.3 million in 2025, reflecting 1% growth in line with Switzerland’s demographic trend as the total population rose to 9 million and the population aged 65 and over increased from 1.7 million to 1.8 million. R
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Switzerland with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Switzerland, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Rx/Reimbursement adult incontinence in Switzerland report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Rx/Reimbursement adult incontinence in Switzerland?
- Which are the leading brands in Rx/Reimbursement adult incontinence in Switzerland?
- How are products distributed in Rx/Reimbursement adult incontinence in Switzerland?
- How is the rise of e-commerce changing the retail and competitive landscape?
- How has COVID-19 impacted demand? Where have sales increased due to stockpiling amidst national lockdown?
- How have enforced home seclusion and social distancing measures following COVID-19 changed usage patterns for Rx/Reimbursement adult incontinence products?
- Where is future growth expected to be most dynamic?
- How important will sustainability and recycling be in generating future growth?
Rx/Reimbursement Adult Incontinence in Switzerland - Category analysis
Key Data Insights
Ageing Population Sustains Growth as Affordability Shapes Selection
Ageing Population Sustains Growth as Affordability Shapes Selection
Kimberly-Clark Introduces Renew Programme for Hard-To-Recycle Products
Declining Stigma Drives Programme Participation as Product Design Normalises Care
E-Commerce Privacy Advantage Expands Access for Mobility-Limited Users
Tissue and Hygiene in Switzerland - Industry Overview
Active Ageing Population Drives Incontinence Growth as Action Entry Intensifies Value Competition
Key Data Insights
Active Ageing Population Drives Incontinence Growth as Action Entry Intensifies Value Competition
Kimberly-Clark Expands Renew Programme across European Markets
Essity Brands Capture Quality Expectations through Innovation
Sustainability Commitments Shape Consumer Choices as Demographics Reshape Category Mix
Active Ageing Population Accelerates Adult Incontinence Expansion
Migros Leverages Consumer Trust to Withstand Private-Label Gains
Supermarkets Retain Leadership as E-Commerce Expands in Discreet Categories
Country Reports Disclaimer
Rx/Reimbursement adult incontinence
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!